AllianceBernstein International Health Care Portfolio EUR I
Performance (in EUR)
Past performance is no indication of current or future performance. These performance data do not take account of the commissions and costs incurred on the issue and redemption of units.
Performance
| 1 month | -10.16% |
|---|---|
| Current year | -9.68% |
| 3 years p.a. | 0.02% |
| 5 years p.a. | 6.61% |
| 10 years p.a. | 7.32% |
| Since inception p.a. | n.a. |
Rolling performance in %
Key figures
| YTD | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| Performance | -9.68% | -11.12% | 0.06% | 37.74% | 102.82% |
| Maximum profit on monthly basis | 5.06% | 5.06% | 8.13% | 12.73% | 12.73% |
| Maximum loss on monthly basis | -6.24% | -6.24% | -6.24% | -7.56% | -9.21% |
| Max drawdown | -15.97% | -19.44% | -19.44% | -19.44% | -25.71% |
| Volatility | 18.55% | 14.40% | 13.70% | 13.73% | 16.68% |
| Sharpe ratio | -1.55 | -0.91 | -0.18 | 0.39 | 0.41 |
| Maximum continuous profit in months | 2 | 4 | 5 | 6 | 6 |
| Maximum continuous loss in months | 1 | 2 | 3 | 3 | 4 |
| Positive months / profit duration in months | 3 | 8 | 22 | 39 | 74 |
| Negative months / loss duration in months | 1 | 5 | 15 | 22 | 47 |
Master data
| Fund name | AllianceBernstein International Health Care Portfolio EUR I |
|---|---|
| Fund management company | AllianceBernstein (Luxembourg) S.à r.l. |
| Fund domicile | Luxembourg |
| Inception date | 24 November 2000 |
| ISIN | LU0251855366 |
| Swiss security no. | 2599840 |
| Fund currency | EUR |
| Appropriation of income | accumulating |
| Issuing commission | |
| Ongoing charges under PRIIP KID as at 27 February 2025 | 1.13% |
| End of financial year | 31 May |
| Paying agent | |
| Fund volume as at 28 February 2025 | 2.44 Mrd. EUR |
| Net asset value (NAV) as at 23 April 2025 | 580.22 EUR |
Portfolio structure
Top holdings of fund volume (in %)
| Eli Lilly & Co. | 10.13% | |
| Unitedhealth Group, Inc. | 7.21% | |
| Roche Holdings AG | 6.38% | |
| Johnson & Johnson | 6.17% | |
| Gilead Sciences | 5.83% | |
| Novo Nordisk A/S ADR | 4.81% | |
| Intuitive Surgical | 4.57% | |
| Cencora Inc. | 3.87% | |
| Merck & Co Inc | 3.85% | |
| Vertex Pharmaceuticals, Inc. | 3.81% |